Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 11, 2015 - Issue
Submit an article Journal homepage
149
Views
12
CrossRef citations to date
0
Altmetric
Review

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis

Emma Vázquez-EspinosaPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, SpainCorrespondence[email protected]
,
Rosa María GirónPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, Spain
,
Rosa Mar Gómez-PunterPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, Spain
,
Elena García-CastilloPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, Spain
,
Claudia ValenzuelaPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, Spain
,
Carolina CisnerosPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, Spain
,
Enrique ZamoraPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, Spain
,
F Javier García-PérezPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, Spain
&
Julio AncocheaPulmonology Department, La Princesa Institute for Health Research, Hospital Universitario de La Princesa, Madrid, Spain
 show all
Pages 407-415 | Published online: 12 Mar 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

E. Vazquez-Espinosa, C. Marcos, T. Alonso, R.M. Giron, R.M. Gomez-Punter, E. Garcia-Castillo, E. Zamora, C. Cisneros, J. Garcia, C. Valenzuela & J. Ancochea. (2016) Tobramycin inhalation powder (TOBI Podhaler®) for the treatment of lung infection in patients with cystic fibrosis. Expert Review of Anti-infective Therapy 14:1, pages 9-17.
Read now

Articles from other publishers (11)

Madhuri Dutta, Sinjini Patra, Shivam Saxena & Anasuya Roychowdhury. 2021. Biomolecular Engineering Solutions for Renewable Specialty Chemicals. Biomolecular Engineering Solutions for Renewable Specialty Chemicals 77 109 .
Imen Ben Chabchoubi, Najet Belkhamssa, Mohamed Ksibi & Olfa Hentati. (2021) Trends in the detection of pharmaceuticals and endocrine-disrupting compounds by Field-Effect Transistors (FETs). Trends in Environmental Analytical Chemistry 30, pages e00127.
Crossref
Alya A. Heirali, Nicole Acosta, Douglas G. Storey, Matthew L. Workentine, Ranjani Somayaji, Isabelle Laforest-Lapointe, Winnie Leung, Bradley S. Quon, Yves Berthiaume, Harvey R. Rabin, Barbara J. Waddell, Laura Rossi, Michael G. Surette & Michael D. Parkins. (2019) The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome. Journal of Cystic Fibrosis 18:6, pages 829-837.
Crossref
Annelies J. Velzen, Joris W.F. Uges, Harry G.M. Heijerman, Bert G.M. Arets, Marianne Nuijsink, Els C. Wiel‐Kooij, Erik M. Maarseveen, Gijsbert A. Zanten, Bas Pullens, Daan J. Touw & Hettie M. Janssens. (2019) Pharmacokinetics and safety of tobramycin nebulization with the I‐neb and PARI‐LC Plus in children with cystic fibrosis: A randomized, crossover study. British Journal of Clinical Pharmacology 85:9, pages 1984-1993.
Crossref
Marcus Hill, Matthew Twigg, Emer A. Sheridan, John G. Hardy, J. Stuart Elborn, Clifford C. Taggart, Christopher J. Scott & Marie E. Migaud. (2019) Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications. Pharmaceutics 11:8, pages 379.
Crossref
Sonia M. Rocha-Sanchez, Olivia Fuson, Shikha Tarang, Linda Goodman, Umesh Pyakurel, Huizhan Liu, David Z. He & Marisa Zallocchi. (2018) Quinoxaline protects zebrafish lateral line hair cells from cisplatin and aminoglycosides damage. Scientific Reports 8:1.
Crossref
Yohei Migiyama, Susumu Hirosako, Kentaro Tokunaga, Emi Migiyama, Takahiro Tashiro, Katsuyuki Sagishima, Hidenobu Kamohara, Yoshihiro Kinoshita & Hirotsugu Kohrogi. (2017) Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndrome. Pulmonary Pharmacology & Therapeutics 45, pages 142-147.
Crossref
Srilekha Panguluri, Praveen Gunda, Laurie Debonnett & Kamal Hamed. (2017) Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis. Clinical Drug Investigation 37:8, pages 795-805.
Crossref
Susanna EspositoChiara RosazzaCalogero Sathya SciarrabbaNicola Principi. (2017) Inhaled Antibiotic Therapy for the Treatment of Upper Respiratory Tract Infections. Journal of Aerosol Medicine and Pulmonary Drug Delivery 30:1, pages 14-19.
Crossref
Jayesh Dhanani, John F. Fraser, Hak-Kim Chan, Jordi Rello, Jeremy Cohen & Jason A. Roberts. (2016) Fundamentals of aerosol therapy in critical care. Critical Care 20:1.
Crossref
Matthew Kruger, Robert Boney, Alexander J. Ordoobadi, Thomas F. Sommers, Josef G. Trapani & Allison B. Coffin. (2016) Natural Bizbenzoquinoline Derivatives Protect Zebrafish Lateral Line Sensory Hair Cells from Aminoglycoside Toxicity. Frontiers in Cellular Neuroscience 10.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.